Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemifloxacin resistance in <i>Mycobacterium tuberculosis</i> without QRDR mutations in <i>gyrA</i> or <i>gyrB</i>: evidence for non-canonical resistance mechanisms.

Microbiology spectrum·2026
Same author

Traditional and Short Course Treatment for Multidrug-Resistant Tuberculosis: A Comparative Study in National Referral Centers.

Tanaffos·2026
Same author

A 15-Year-Old Healthy Girl with Streaky Hemoptysis and Cavitary Lung Lesion.

Tanaffos·2026
Same author

Diagnostic Accuracy of Interleukin 27 for the Diagnosis of Pleural Tuberculosis.

Tanaffos·2026
Same author

Assessing the Economic Benefit of Mass COVID-19 Vaccination Program in Iran: A Real-World Modeling Study.

International journal of health policy and management·2026
Same author

Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases.

Frontiers in microbiology·2026
Same journal

The Effect of Acu-TENS Current on Shortness of Breath and Lung Function Indicators in Patients with COPD.

Tanaffos·2026
Same journal

Pulmonary Artery Diameter During Pregnancy.

Tanaffos·2026
Same journal

Evaluation of E-Cigarette Effects on Gene Expression Profile of Human Bronchial Epithelial Cells: A System Biology Approach.

Tanaffos·2026
Same journal

Visualization and Analysis of the Role of an Inflated Tracheostomy Tube Cuff in the Human: A Preliminary Study.

Tanaffos·2026
Same journal

New Insights into Pulmonary Arterial Hypertension Treatment with Non-Coding RNAs: What is the Best Option, microRNAs or Small-Interfering RNAs?

Tanaffos·2026
Same journal

COVID-19: A Systematic Review of Metabolomics Data and Predicting Potential Biomarkers Based on Pathway Analysis.

Tanaffos·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.7K

Tuberculosis in Solid Organ Transplantation.

Afshin Mohammad Alizadeh1, Majid Marjani2, Afshin Moniri2

  • 1Bone Marrow Transplantation Department, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Tanaffos
|February 18, 2017
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) is a significant risk for organ transplant recipients. This review covers TB diagnosis and treatment challenges in this patient group.

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.5K
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.7K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.5K
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.8K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Transplantation

Background:

  • Solid organ transplant recipients are at increased risk of opportunistic infections.
  • Active tuberculosis (TB) is a major concern in this vulnerable population.
  • Managing TB in transplant patients presents unique diagnostic and therapeutic challenges.

Purpose of the Study:

  • To review the clinical manifestations of TB in solid organ transplant recipients.
  • To discuss diagnostic approaches for latent TB infection.
  • To outline treatment strategies for both latent and active TB in this population.

Main Methods:

  • Literature review of clinical manifestations, diagnosis, and treatment of TB in solid organ transplant recipients.
  • Discussion of challenges due to limited randomized clinical trials.
  • Synthesis of current knowledge on managing TB in immunocompromised patients.

Main Results:

  • TB is a critical opportunistic infection in solid organ transplant recipients.
  • Diagnosis of latent and active TB is complicated by the lack of specific clinical trials.
  • Treatment protocols require careful consideration of immunosuppression and drug interactions.

Conclusions:

  • Effective management of TB in solid organ transplant recipients requires a thorough understanding of its varied presentations.
  • Diagnostic strategies for latent TB should be optimized for this high-risk group.
  • Tailored treatment approaches are essential for both latent and active TB to improve outcomes and prevent transmission.